Partnering with India to Fight AIDS (2008)

Indian woman with child

India now has the largest number of people living with HIV/AIDS of any country in the world.

Almost half of new cases are women, with a subsequent rise in infected children. Furthermore, HIV infection increases susceptibility to tuberculosis, still the country’s biggest communicable disease killer of adults, and many HIV/AIDS patients die within months of contracting TB if they are not treated properly and promptly.

  Global Community

Partnering with India to Fight AIDS

Can-Do Compassion in Haiti

A Different Kind of Sunshine

That's why the Emory Vaccine Center, one of the largest and most successful academic vaccine centers in the world, has joined forces with the International Center for Genetic Engineering and Biotechnology (ICGEB), a program founded in New Delhi by the World Health Organization. In the new ICGEB-Emory Center for Global Vaccines, Indian and Emory scientists work together to develop new vaccines for HIV/AIDS, tuberculosis, and other infectious diseases that disproportionately affect India and other parts of the developing world.

Emory scientists already have one AIDS vaccine in human clinical trials and others in development, and the Indian Ministry of Science will help the team develop a new AIDS vaccine designed specifically for the strain of HIV most prevalent in India.

ICGEB has vaccines ready for testing for malaria, hepatitis C and E, dengue fever, and TB. The new center also will help move new vaccines from the laboratory through the complex testing, approval, and manufacturing process to their use in local health centers in Indian towns and villages.

Rafi Ahmed of the Emory Vaccine Center